Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001252990 | SCV001428481 | likely pathogenic | Developmental and epileptic encephalopathy, 7 | 2019-01-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001879862 | SCV002127368 | pathogenic | Early infantile epileptic encephalopathy with suppression bursts | 2023-04-09 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ2 protein function. ClinVar contains an entry for this variant (Variation ID: 975869). This missense change has been observed in individual(s) with clinical features of KCNQ2-related conditions (PMID: 30182498, 31552204). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 285 of the KCNQ2 protein (p.Pro285Ser). |